Mira Johri – The Conversation

The TRIPS waiver enables WTO member states to manufacture and distribute COVID-19 drugs and medical supplies that would normally be protected by patents. (Pixabay)

November 5, 2020

COVID‑19 drug and vaccine patents are putting profit before people

Ronald Labonte, L’Université d’Ottawa/University of Ottawa and Mira Johri, Université de Montréal

The TRIPS waiver makes COVID-19 treatments more accessible globally by enabling manufacture and distribution of COVID-19 drugs and medical supplies that would normally be protected by patents.

Le technicien de recherche Leon McFarlane manipule un échantillon de sang d'un volontaire dans le laboratoire de l'Imperial College de Londres, où un vaccin Covid-19 est en cours de développement, le 30 juillet. (AP Photo/Kirsty Wigglesworth)

October 6, 2020

Le Canada achète beaucoup de vaccins contre la Covid‑19. Voici pourquoi il devrait faire plus pour les pays pauvres

Ronald Labonte, L’Université d’Ottawa/University of Ottawa; Katrina Plamondon, University of British Columbia; Mira Johri, Université de Montréal, and Srinivas Murthy, University of British Columbia

Les pays riches, comme le Canada, achètent plus de la moitié de l’offre mondiale de vaccins à court terme.

Research technician Leon McFarlane handles a blood sample from a volunteer in the laboratory at Imperial College in London, where a COVID-19 vaccine is under development, on July 30, 2020. (AP Photo/Kirsty Wigglesworth)

September 27, 2020

Canada’s ‘me first’ COVID‑19 vaccine strategy may come at the cost of global health

Ronald Labonte, L’Université d’Ottawa/University of Ottawa; Katrina Plamondon, University of British Columbia; Mira Johri, Université de Montréal, and Srinivas Murthy, University of British Columbia

With $1 billion in advance purchase agreements for COVID-19 vaccines, Canada has joined the vaccine nationalists: rich countries buying up more than half the global short-term supply of vaccine.

Contact Mira for